Nucleic acid amplification controls

Details for Australian Patent Application No. 2002211795 (hide)

Owner Impath, Inc

Inventors Hengst, James C. D.; Chiklis, Gregory R.

Agent Cullen & Co

Pub. Number AU-B-2002211795

PCT Pub. Number WO02/33129

Priority 60241038 17.10.00 US

Filing date 17 October 2001

Wipo publication date 29 April 2002

Acceptance publication date 11 October 2007

International Classifications

C12Q 1/70 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

C07K 14/02 (2006.01) Peptides having more than 20 amino acids

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

C12N 7/06 (2006.01) Viruses, e.g. bacteriophages

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

11 October 2007 Application Accepted

  Published as AU-B-2002211795

29 November 2007 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 22 Oct 2007. Address for service in Australia - Cullen & Co Level 26 239 George Street Brisbane QLD 4000

7 February 2008 Standard Patent Sealed

17 April 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 22 Oct 2007

26 June 2008 Assignment Registered

  Impath, Inc The patent has been assigned to Zeptometrix Corporation

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002211796

2002211794